Dr Vivien Sutton
Honorary (Senior Fellow)
The Sir Peter MacCallum Department of Oncology
88 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity
DOI: 10.1016/j.celrep.2025.1166652025
Journal article
DLBCL tumor microenvironment archetype and CD4 T cell conversion to cytotoxic cells are required for response to glofitamab
DOI: 10.1182/blood-2025-5572025
Journal article
197 | CD4 T CELL RECRUITMENT AND DIFFERENTIATION INTO A CYTOTOXIC PHENOTYPE IS ASSOCIATED WITH THE TREATMENT OF PATIENTS WITH GLOFITAMAB TOGETHER WITH R‐CHOP OR POLA‐R‐CHP
DOI: 10.1002/hon.70094_1972024
Journal article
Pharmacologic inhibition of dipeptidyl peptidase 1 (cathepsin C) does not block in vitro granzyme-mediated target cell killing by CD8 T or NK cells
DOI: 10.3389/fphar.2024.13967102022
Journal article
Beyond target cell death – Granzyme serine proteases in health and disease
DOI: 10.1016/j.mam.2022.1011522022
Journal article
Small Molecule Inhibitors of Lymphocyte Perforin as Focused Immunosuppressants for Infection and Autoimmunity
DOI: 10.1021/acs.jmedchem.2c013382022
Journal article
The effects of B-cell–activating factor on the population size, maturation and function of murine natural killer cells
DOI: 10.1111/imcb.12585
RECENT SCHOLARLY WORKS
2022
Journal article
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction
DOI: 10.1126/sciadv.abm94272022
Journal article
Preclinical Activity and Pharmacokinetic/Pharmacodynamic Relationship for a Series of Novel Benzenesulfonamide Perforin Inhibitors
DOI: 10.1021/acsptsci.2c000092022
Journal article
Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1
DOI: 10.1182/blood.2021013477